• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

17例局部复发子宫颈癌患者行盆腔廓清术的围手术期情况及近期疗效分析

Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer

摘要:

目的:探讨局部复发子宫颈癌患者行盆腔廓清术的围手术期情况及近期效果。方法:收集2015年10月—2018年5月北京大学人民医院行盆腔廓清术的局部复发子宫颈癌患者共17例,回顾性分析其临床病理特点、手术情况、住院费用、术后并发症及生存情况。结果:(1)17例局部复发子宫颈癌患者的中位年龄为51岁(27~64岁);病理类型:鳞癌13例,腺癌2例,腺鳞癌2例;初次治疗时13例接受了放疗、4例未放疗。(2)17例局部复发子宫颈癌患者均行盆腔廓清术,其中行全盆腔廓清术(包括膀胱、部分输尿管、直肠及部分阴道)9例、前盆腔廓清术(包括膀胱、部分输尿管及部分阴道)8例,17例患者均顺利完成手术;中位手术时间为450 min(240~760 min),中位术中出血量为2 200 ml(200~8 400 ml),中位术后住院时间为17 d(9~55 d),中位住院费用为83 857元(41 588~296 354元)。(3)17例行盆腔廓清术的患者中,16例出现早期并发症,最常见者为发热(14例);14例出现晚期并发症,最常见者为泌尿系统感染(12例)。(4)17例行盆腔廓清术患者的中位总生存时间为26.0个月(3~44个月);中位无瘤生存时间为9.0个月(2~44个月),其中13例初次治疗接受放疗患者的中位无瘤生存时间为9.0个月(2~30个月),4例初始治疗未放疗患者的中位无瘤生存时间10.5个月(2~44个月),两者比较,差异无统计学意义( P=0.820);11例患者在盆腔廓清术后接受了辅助治疗,中位无瘤生存时间为12.0个月(2~44个月),6例患者未接受术后辅助治疗,中位无瘤生存时间为5.0个月(2~9个月),两者比较,差异无统计学意义( P=0.018)。 结论:盆腔廓清术的手术范围大、术后并发症多、住院费用高,术后接受辅助治疗可改善部分患者的无瘤生存时间,其临床价值和卫生经济学价值有待进一步探讨。

更多
abstracts:

Objective:To investigate the perioperative situation and recent effect of pelvic exenteration for patients with locally recurrent cervical cancer.Methods:A total of 17 patients with locally recurrent cervical cancer who underwent pelvic exenteration in Peking University People's Hospital from October 2015 to May 2018 were retrospectively analyzed for their clinical and pathological characteristics, surgical conditions, hospitalization costs, postoperative complications, and survival situation.Results:(1) The median age of 17 patients with locally recurrent cervical cancer was 51 years (range 27-64 years). Pathological type: 13 cases of squamous cell carcinoma, 2 cases of adenocarcinoma, and 2 cases of adenosquamous carcinoma. Thirteen patients received radiotherapy during the initial treatment and 4 patients did not receive radiotherapy. (2) Pelvic exenteration was performed in 17 patients with locally recurrent cervical cancer, of which 9 cases were performed with total pelvic exenteration (operation range including radical cystectomy, partial urethrectomy rectectomy and partial vaginalectomy), and 8 cases with anterior pelvic exenteration operation (operation range including: radical cystectomy, part of urethrectomy and part of vaginalectomy). Of the 17 patients successfully completed the operation. The median operation time was 450 minutes (range 240-760 minutes), the median intraoperative blood loss was 2 200 ml (range 200- 8 400 ml), the median postoperative hospital stay was 17 days (range 9-55 days), the median hospital cost was 83 857 yuan (range 41 588-296 354 yuan). (3) Of the 17 patients underwent pelvic exenteration, 16 of them had early complications, the most common one was fever (14 cases). Fourteen of them had late complications, and the most common one was a urinary system infection (12 cases). (4) The median overall survival time was 26.0 months (range 3-44 months), the median progression-free survival (PFS) time was 9.0 months (range 2-44 months). Among them, 13 patients received radiation therapy during the initial treatment, the median PFS time was 9.0 months (range 2-30 months); 4 patients did not receive radiation therapy in the initial treatment, the median PFS time was 10.5 months (range 2-44 months).Eleven patients received adjuvant therapy after pelvic exenteration, the median PFS time was 12.0 months (range 2-44 months); 6 patients did not receive adjuvant therapy, the median PFS time was 5.0 months (range 2-9 months).Conclusions:Pelvic exenteration has a wide range of operations, many postoperative complications, and high hospitalization costs. Adjuvant treatment after pelvic exenteration could improve the PFS time for some patients. Its clinical value and health economic value need to be further explored.

More
作者: 邓浩 [1] 王建六 [1] 王志启 [1] 李晓伟 [1] 胡浩 [2] 杨波 [2] 张学民 [3] 沈凯 [4] 郭鹏 [4] 梁斌 [4]
期刊: 《中华妇产科杂志》2020年55卷4期 259-265页 MEDLINEISTICPKUCSCD
栏目名称: 临床研究
DOI: 10.3760/cma.j.cn112141-20200119-00049
发布时间: 2024-03-19
基金项目:
国家科技支撑计划 National Science and Technology Infrastructure Program
  • 浏览:379
  • 下载:341

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷